INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 412m ago
HOUSE PTR12m ago
SEC 13F11m ago
ROBINHOOD CHAIN11m ago
SEC FORM 4/Option exerciseVerified data

Haines John R reported CELU

Senior Exec Vice President · Celularity Inc · Class A Common Stock

Side
M
Value
—
Shares
1,641
Price
—
Executed
Apr 13, 2026
Disclosed
Apr 15, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 13 executedApr 15, 2026 disclosed

CELU · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
13/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+5 / 25

No reported dollar value · 5.6% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CELU

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    HR
    Haines John RSenior Exec Vice President
    CELUCelularity Inc
    Option exercise
    		M—
    1,641 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    BS
    Brigido StephenPres., Functional Regeneration
    CELUCelularity Inc
    Option exercise
    		M—
    821 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BS
    Brigido StephenPres., Functional Regeneration
    CELUCelularity Inc
    Tax withholding
    		F$343
    268 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HR
    Haines John RSenior Exec Vice President
    CELUCelularity Inc
    Tax withholding
    		F$746
    583 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HJ
    Hariri Robert JDirector, Chief Executive Officer
    CELUCelularity Inc
    Tax withholding
    		F$1,513
    1,182 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HJ
    Hariri Robert JDirector, Chief Executive Officer
    CELUCelularity Inc
    Option exercise
    		M—
    3,281 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BS
    Brigido StephenPres., Functional Regeneration
    CELUCelularity Inc
    Option exercise
    		M—
    821 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HJ
    Hariri Robert JDirector, Chief Executive Officer
    CELUCelularity Inc
    Option exercise
    		M—
    3,281 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    17
    LV
    LeVien VincentDirector
    CELUCelularity Inc
    Grant or award
    		A—
    28.8K sh
    		Jan 12, 2026Jan 14, 2026
    traded Jan 12, 2026
    		+2dSEC FORM 4

    Evidence

    13
    LD
    Ling Geoffrey M.D.Director
    CELUCelularity Inc
    Grant or award
    		A—
    19.2K sh
    		Jan 12, 2026Jan 14, 2026
    traded Jan 12, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001493152-26-016833
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 13, 2026
    Published
    Apr 15, 2026
    Ingested by INSIDER
    Nov 5, 04:04 UTC
    Last re-read
    Nov 5, 04:04 UTC

    Extracted facts

    Filer
    Haines John R
    Role
    Senior Exec Vice President
    Transaction
    Option exerciseAs filed: “M”
    Asset
    Celularity Inc
    Ticker
    CELU
    Shares
    1,641
    Price per share
    $0
    Execution date (reported)
    Apr 13, 2026
    Owned after transaction
    30.8K shares
    Days from execution to publication
    2

    What this establishes

    Haines John R filed this Form 4 reporting a option exercise of CELU on Apr 13, 2026. It became public on Apr 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Senior Exec Vice President
    Haines John Rcik:0001867686
    Issuer
    Celularity Inccik:0001752828

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.